AI-guided anti-HER2 targeted therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AI-guided anti-HER2 targeted therapy, covering 2026-04-14 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: Artificial Intelligence Model-Guided Neoadjuvant Anti-HER2 Targeted Therapy [Phase 3]